A base editing platform for the correction of cancer driver mutations unmasks conserved p53 transcription programs

Pascal Wang1, Rituparno Sen1, Frank Buchholz2,3,4

  • 1Medical Systems Biology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.

Genome Biology
|July 22, 2025
PubMed
Abstract

Insights

Base editing corrects cancer hotspot mutations, revealing shared p53-dependent programs that suppress tumors. This approach uncovers dependencies on mutant allele expression and offers new therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer hotspot mutations drive tumorigenesis and present therapeutic targets.
  • Base editing offers a novel method to investigate driver mutation biology.

Purpose of the Study:

  • To develop a versatile platform for investigating cancer hotspot mutations using adenine base editing.
  • To analyze the functional impact and transcriptional consequences of correcting TP53 hotspot mutations.

Main Methods:

  • Utilized adenine base editing to correct TP53 hotspot mutations in cancer cell lines.
  • Employed transcriptomic profiling (mRNA sequencing) to assess transcriptional changes post-correction.
  • Investigated the impact of mutation correction across diverse tissue origins and co-occurring mutations.

Main Results:

  • Demonstrated that correcting TP53 mutations restores conserved tumor-suppressive transcriptional programs.
  • Highlighted a shared p53-dependent regulatory network active across different cancer types.
  • Revealed dependencies on mutant allele expression for tumor cell function.

Conclusions:

  • Established a robust framework for studying cancer mutation transcriptional dynamics.
  • Showcased the restoration of conserved biological processes through p53 correction.
  • Indicated potential for future targeted therapies based on p53 reactivation.